-
公开(公告)号:US5399574A
公开(公告)日:1995-03-21
申请号:US838233
申请日:1992-03-03
IPC分类号: C07D413/14 , A61K20060101 , A61K31/40 , A61K31/404 , A61K31/4045 , A61K31/405 , A61K31/41 , A61K31/415 , A61K31/42 , A61K31/421 , A61K31/422 , A61K31/425 , A61K31/44 , A61K31/4427 , A61K31/445 , A61K31/4523 , A61P9/00 , A61P25/04 , A61P25/06 , A61P43/00 , C07D20060101 , C07D401/14 , C07D403/06 , C07D403/14 , C07D413/06 , C07D413/12 , C07D417/04 , C07D417/06 , C07D417/14 , C12P21/08
CPC分类号: C07D401/14 , C07D403/06 , C07D413/06 , C07D413/14
摘要: ##STR1## The present invention is concerned with compounds of formula (I), wherein n is an integer of from 0 to 3: W is a group of formula (i), (ii), or (iii), wherein R is hydrogen or C
1-4 alkyl, X is --O--, --S--, --NH--, or --CH
2 --, Y is oxygen or sulphur and the chiral center (*) in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions: and Z is a group of formula (iv), (v), or (vi), wherein R
1 and R
2 are independently selected from hydrogen and C
1-4 alkyl and R
3 is hydrogen or C
1-4 alkyl; and their salts, solvates and physiologically functional derivatives, with processes for their preparation, with medicaments containing them and with their use as therapeutic agents, particularly in the prophylaxis and treatment of migraine.摘要翻译: PCT No.PCT / GB91 / 00908 Sec。 371日期:1992年3月3日 102(e)1992年3月3日PCT PCT 1991年6月6日PCT公布。 WO91 / 18897 PCT出版物 1991年12月12日,1991年12月12日,本发明涉及式(I)化合物,其中n为0〜3的整数:W为式(i)的基团, (ii)或(iii)其中R是氢或C 1-4烷基,X是-O - , - S - , - NH-或-CH 2 - ,Y是氧或硫,手性中心(*) 在式(ⅰ)或(ⅱ)中,为(S)或(R)的形式,或为其混合物,Z为式(ⅳ),(ⅴ)或(vi) R1和R2独立地选自氢和C1-4烷基,R3是氢或C1-4烷基; 及其盐,溶剂合物和生理功能衍生物,其制备方法,含有它们的药物和用作治疗剂,特别是在预防和治疗偏头痛中。
-
公开(公告)号:US5225431A
公开(公告)日:1993-07-06
申请号:US660966
申请日:1991-02-26
IPC分类号: C07D209/16 , C07D403/06 , C07D405/14 , C07D409/14 , C07D413/06
CPC分类号: C07D403/06 , C07D209/16 , C07D405/14 , C07D409/14 , C07D413/06
摘要: The present invention is concerned with compounds of formula (I) ##STR1## wherein R, R.sup.1 and R.sup.2 are independently selected from hydrogen and C.sub.1-4 alkyl;R.sup.3 and R.sup.4 are independently selected from hydrogen, C.sub.1-6 alkyl (including cycloalkyl) and aryl (wherein the alkyl or aryl group, which latter includes benzyl, is optionally substituted by one or more atoms or groups independently selected from halogen, C.sub.1-4 alkyl and aryl), provided R.sup.3 benzyl or substituted benzyl when R.sup.4 =H;m is an integer of from 0 to 2;n is an integer of from 0 to 3;(W) is a group of formula (i), (ii), (iii), or (iv) ##STR2## wherein Y is selected from oxygen, methylene and >N--R.sup.5, where R.sup.5 is hydrogen, C.sub.1-4 alkyl, or benzyl, Z and Z' are independently selected from >C.dbd.O, >C.dbd.S and methylene, and the chiral center * in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions;X is a group selected fromaryl (including heteroaryl)xanthenyldibenzofuranyl which group is optionally substituted;and salts and solvates thereof, the preparation of these compounds, pharmaceutical formulations containing them and their use in medicine, particularly in the treatment of migraine.
摘要翻译: 本发明涉及式(I)化合物:其中R 1,R 2和R 2独立地选自氢和C 1-4烷基; R 3和R 4独立地选自氢,C 1-6烷基(包括环烷基)和芳基(其中后者包括苄基的烷基或芳基任选被一个或多个独立地选自卤素,C 1-4的一个或多个原子或基团取代 烷基和芳基),当R 4 = H时提供R 3苄基或取代的苄基; m为0〜2的整数; n为0〜3的整数, (ⅰ)Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y Y 选自氧,亚甲基和> N-R5,其中R5是氢,C1-4烷基或苄基,Z和Z'独立地选自C = O,> C = S和亚甲基,手性中心* 在式(ⅰ)或(ⅱ)中为其(S)或(R)形式或其任何比例的混合物; X是选自基团任选取代的芳基(包括杂芳基)呫吨基二苯并呋喃基的基团; 其盐和溶剂合物,这些化合物的制备,含有它们的药物制剂及其在医药中的用途,特别是用于治疗偏头痛。
-
公开(公告)号:US5863935A
公开(公告)日:1999-01-26
申请号:US471229
申请日:1995-06-06
IPC分类号: C07D413/14 , A61K20060101 , A61K31/40 , A61K31/404 , A61K31/4045 , A61K31/405 , A61K31/41 , A61K31/415 , A61K31/42 , A61K31/421 , A61K31/422 , A61K31/425 , A61K31/44 , A61K31/4427 , A61K31/445 , A61K31/4523 , A61P9/00 , A61P25/04 , A61P25/06 , A61P43/00 , C07D20060101 , C07D401/14 , C07D403/06 , C07D403/14 , C07D413/06 , C07D413/12 , C07D417/04 , C07D417/06 , C07D417/14 , C12P21/08 , C07D209/04
CPC分类号: C07D401/14 , C07D403/06 , C07D413/06 , C07D413/14
摘要: ##STR1## The present invention is concerned with compounds of formula (I), wherein n is an integer of from 0 to 3: W is a group of formula (i), (ii), or (iii), wherein R is hydrogen or C
1-4 alkyl, X is --O--, --S--, --NH--, or --CH
2 --, Y is oxygen or sulphur and the chiral center (*) in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions: and Z is a group of formula (iv), (v), or (vi), wherein R
1 and R
2 are independently selected from hydrogen and C
1-4 alkyl and R
3 is hydrogen or C
1-4 alkyl; and their salts, solvates and physiologically functional derivatives, with processes for their preparation, with medicaments containing them and with their use as therapeutic agents, particularly in the prophylaxis and treatment of migraine.摘要翻译: (ⅰ)
>>>>>>(((>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>((( I),其中n是0-3的整数:W是式(i),(ii)或(iii)的基团,其中R是氢或C 1-4烷基,X是-O-, - S-,-NH-或-CH 2 - ,Y是氧或硫,式(i)或(ii)中的手性中心(*)是其(S)或(R)形式或其混合物 任何比例:Z为式(ⅳ),(Ⅴ)或(vi)的基团,其中R1和R2独立地选自氢和C1-4烷基,R3是氢或C1-4烷基; 及其盐,溶剂合物和生理功能衍生物,其制备方法,含有它们的药物和用作治疗剂,特别是在预防和治疗偏头痛中。 -
公开(公告)号:US5466699A
公开(公告)日:1995-11-14
申请号:US341206
申请日:1994-12-05
IPC分类号: C07D413/14 , A61K20060101 , A61K31/40 , A61K31/404 , A61K31/4045 , A61K31/405 , A61K31/41 , A61K31/415 , A61K31/42 , A61K31/421 , A61K31/422 , A61K31/425 , A61K31/44 , A61K31/4427 , A61K31/445 , A61K31/4523 , A61P9/00 , A61P25/04 , A61P25/06 , A61P43/00 , C07D20060101 , C07D401/14 , C07D403/06 , C07D403/14 , C07D413/06 , C07D413/12 , C07D417/04 , C07D417/06 , C07D417/14 , C12P21/08
CPC分类号: C07D401/14 , C07D403/06 , C07D413/06 , C07D413/14
摘要: ##STR1## The present invention is concerned with compounds of formula (I), wherein n is an integer of from 0 to 3: W is a group of formula (i), (ii), or (iii), wherein R is hydrogen or C
1-4 alkyl, X is --O--, --S--, --NH--, or --CH
2 --, Y is oxygen or sulphur and the chiral center (*) in formula (i) or (ii) is in its (S) or (R) form or is a mixture thereof in any proportions: and Z is a group of formula (iv), (v), or (vi), wherein R
1 and R
2 are independently selected from hydrogen and C
1-4 alkyl and R
3 is hydrogen or C
1-4 alkyl; and their salts, solvates and physiologically functional derivatives, with processes for their preparation, with medicaments containing them and with their use as therapeutic agents, particularly in the prophylaxis and treatment of migraine.摘要翻译: (ⅰ)
>>>>>>(((>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>>((( I),其中n是0-3的整数:W是式(i),(ii)或(iii)的基团,其中R是氢或C 1-4烷基,X是-O-, - S-,-NH-或-CH 2 - ,Y是氧或硫,式(i)或(ii)中的手性中心(*)是其(S)或(R)形式或其混合物 任何比例:Z为式(ⅳ),(Ⅴ)或(vi)的基团,其中R1和R2独立地选自氢和C1-4烷基,R3是氢或C1-4烷基; 及其盐,溶剂合物和生理功能衍生物,其制备方法,含有它们的药物和用作治疗剂,特别是在预防和治疗偏头痛中。
-
-
-